This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Oct;2(10):996-997.

doi: 10.1038/s43018-021-00270-0.

A PRC1-RNF2 knockout punch for cancer

Janneke G C Peeters¹, Michel DuPage²

Affiliations

Affiliations

¹ Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
² Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. dupage@berkeley.edu.

PMID: 35121885
DOI: 10.1038/s43018-021-00270-0

Free article

Comment

A PRC1-RNF2 knockout punch for cancer

Janneke G C Peeters et al. Nat Cancer. 2021 Oct.

Free article

. 2021 Oct;2(10):996-997.

doi: 10.1038/s43018-021-00270-0.

Authors

Janneke G C Peeters¹, Michel DuPage²

Affiliations

¹ Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
² Division of Immunology and Pathogenesis, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. dupage@berkeley.edu.

PMID: 35121885
DOI: 10.1038/s43018-021-00270-0

No abstract available

PubMed Disclaimer

Comment on

RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4⁺ T-cell-dependent antitumor immunity.
Zhang Z, Luo L, Xing C, Chen Y, Xu P, Li M, Zeng L, Li C, Ghosh S, Della Manna D, Townes T, Britt WJ, Wajapeyee N, Sleckman BP, Chong Z, Leavenworth JW, Yang ES. Zhang Z, et al. Nat Cancer. 2021 Oct;2(10):1018-1038. doi: 10.1038/s43018-021-00263-z. Epub 2021 Oct 22. Nat Cancer. 2021. PMID: 35121884 Free PMC article.

References

1. Kalbasi, A. & Ribas, A. Nat. Rev. Immunol. 20, 25–39 (2020). - DOI
1. Garber, K. Nat. Biotechnol. 38, 909–912 (2020). - DOI
1. Peng, D. et al. Nature 527, 249–253 (2015). - DOI
1. Chan, H. L. et al. Nat. Commun. 9, 3377 (2018). - DOI
1. Wu, J. et al. Pathol. Res. Pract. 215, 152523 (2019). - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

DP2 CA247830/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- eScholarship, University of California - Access Free Full Text
Medical
- MedlinePlus Health Information